| Market Cap | ₹2,031Cr |
| ROE | 16.57% |
| P/E Ratio(TTM) | 35.82 |
| EPS(TTM) | 19.61 |
| P/B Ratio | 5.94 |
| Dividend Yield | 0.65% |
| Industry P/E | 40.28 |
| Book Value | 118.32 |
| Debt to Equity | 0.01 |
| Face Value | 1 |
| Parent Organisation | Amrutanjan Health Care Limited |
| Managing Director | Mr. S. Sambhu Prasad |
| NSE Symbol | AMRUTANJAN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 58.99 | ||
| Ajanta Pharma | NA (0.00%) | 32.29 | ||
| Gland Pharma | NA (0.00%) | 36.94 | ||
| Eris Lifesciences | NA (0.00%) | 48.78 |